China National Medicines (SHSE:600511) Cyclically Adjusted FCF per Share: ¥1.74 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600511 China National Medicines Corp Ltd SHSE:600511
90 GF Score
Price ¥26.77
GF Value ¥32.09
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is China National Medicines Cyclically Adjusted FCF per Share?

China National Medicines SHSE:600511 -0.04% 90 Cyclically Adjusted FCF per Share is ¥1.74 as of Jun. 2026. GuruFocus rates SHSE:600511 with a GF Score™ of 90/100 and a GF Value™ of ¥32.09 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

China National Medicines's adjusted free cash flow per share for the three months ended in Jun. 2026 was ¥1.240. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥1.74 for the trailing ten years ended in Jun. 2026.

During the past 12 months, China National Medicines's average Cyclically Adjusted FCF Growth Rate was 0.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 21.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of China National Medicines was 40.40% per year. The lowest was 13.40% per year. And the median was 28.90% per year.

As of today (2026-08-29), China National Medicines's current stock price is ¥26.77. China National Medicines's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ¥1.74. China National Medicines's Cyclically Adjusted Price-to-FCF of today is 15.39.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China National Medicines was 129.43. The lowest was 13.11. And the median was 33.01.


China National Medicines  (SHSE:600511) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

China National Medicines's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=26.77/1.74
=15.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China National Medicines was 129.43. The lowest was 13.11. And the median was 33.01.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


China National Medicines Cyclically Adjusted FCF per Share Related Terms


China National Medicines Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for China National Medicines's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Medicines Cyclically Adjusted FCF per Share Chart

China National Medicines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 1.50 1.83 2.01 2.19

China National Medicines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 1.67 2.19 1.67 1.74

SHSE:600511 vs MCK, COR, CAH: Cyclically Adjusted FCF per Share Comparison

For the Medical Distribution subindustry, China National Medicines's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Medicines Cyclically Adjusted Price-to-FCF vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where China National Medicines's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600511
90GF Score
China National Medicines Corp Ltd SHSE:600511
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China National Medicines Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China National Medicines's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.24/116.0564*116.0564
=1.240

Current CPI (Jun. 2026) = 116.0564.

China National Medicines Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.394 102.400 -0.447
201612 0.902 102.600 1.020
201703 -0.455 103.200 -0.512
201706 -0.252 103.100 -0.284
201709 -0.158 104.100 -0.176
201712 2.122 104.500 2.357
201803 0.007 105.300 0.008
201806 0.607 104.900 0.672
201809 0.467 106.600 0.508
201812 0.026 106.500 0.028
201903 -1.147 107.700 -1.236
201906 1.992 107.700 2.147
201909 0.486 109.800 0.514
201912 0.892 111.200 0.931
202003 -1.548 112.300 -1.600
202006 2.710 110.400 2.849
202009 -0.653 111.700 -0.678
202012 1.123 111.500 1.169
202103 -1.608 112.662 -1.656
202106 2.634 111.769 2.735
202109 -0.711 112.215 -0.735
202112 2.153 113.108 2.209
202203 -1.763 114.335 -1.790
202206 1.753 114.558 1.776
202209 -0.373 115.339 -0.375
202212 3.386 115.116 3.414
202303 -1.546 115.116 -1.559
202306 1.237 114.558 1.253
202309 0.191 115.339 0.192
202312 3.539 114.781 3.578
202403 -2.305 115.227 -2.322
202406 0.813 114.781 0.822
202409 -0.005 115.785 -0.005
202412 3.524 114.893 3.560
202503 -2.519 115.116 -2.540
202506 0.490 114.907 0.495
202509 -0.742 115.471 -0.746
202512 5.339 115.832 5.349
202603 -4.771 116.303 -4.761
202606 1.240 116.056 1.240

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥1.74 mean?
China National Medicines (SHSE:600511) has a Cyclically Adjusted FCF per Share of ¥1.74 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on China National Medicines and its competitors.
Is China National Medicines' Cyclically Adjusted FCF per Share too high?
China National Medicines' current Cyclically Adjusted FCF per Share is ¥1.74. Overall, China National Medicines has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Medicines' Cyclically Adjusted FCF per Share compare to MCK and COR?
China National Medicines' Cyclically Adjusted FCF per Share of ¥1.74 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Distribution company?
A good Cyclically Adjusted FCF per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on China National Medicines and its competitors. China National Medicines's current Cyclically Adjusted FCF per Share is ¥1.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Medicines (SHSE:600511) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥32.09, compared to a current price of ¥26.77 — trading 16.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥1.74. China National Medicines' overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For China National Medicines (SHSE:600511), the current Cyclically Adjusted FCF per Share is ¥1.74 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China National Medicines (SHSE:600511) Overvalued in 2026?

Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued. The current stock price of ¥26.77 is trading 16.6% below its estimated GF Value™ of ¥32.09. GuruFocus considers China National Medicines to be Modestly Undervalued.

Key valuation signals for SHSE:600511:

  • Cyclically Adjusted FCF per Share: ¥1.74
  • GF Value™: ¥32.09 vs. price of ¥26.77 (16.6% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China National Medicines Business Description

Address No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
90GF Score

Get the complete analysis for SHSE:600511

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.77
Price
¥32.09
GF Value